The anti-trading platform
Own great businesses.
Then never sell.
Buy a handful of companies you'd be happy to hold for a decade. Pre-define the few reasons you'd ever let one go. Then stop touching it. Time in the market — not timing the market.
Every investing app secretly sells you activity — trades, alerts, forty app-opens a day.
We sell the opposite: conviction and patience.
A platform whose whole product is telling you to do less and check it less. That contradiction is the point. No blinking tickers, no R:R, no urgency — it should feel like the calm after you quit gambling.
What lives here
The Never Sell List
A public, ranked basket of hold-forever businesses. Each one names its moat, its “why never sell,” and — the part everyone skips — the exact conditions under which you finally would. Naming the exits is what earns the word.
The curve, not the candle
Trading platforms show you the next hour. We show you the next decade: total return with dividends reinvested, and the real, compounding cost of selling early.
Own what the greats own
The books of the investors who never flinch — decades-held positions read as conviction role models, not stock tips. Learn the temperament, not just the tickers.
Video is the spine
Every video becomes a permanent, searchable page. The channel is the reach; the platform is its evergreen memory. Watch once — reference forever.
The behavioral edge
The real moat isn't the pick — it's not selling it. Tools and content built to hold you through a −40% drawdown: the arithmetic of churn and taxes, the psychology of conviction. The anti-panic platform.
The lists
Ranked baskets of businesses worth owning through the noise. Start here, then read each name's case for itself.
Claude-managed fund
15Live AI-managed equity portfolio - current allocations of the publicly-documented Claude-run $50K book. Rebalanced by the model on its own cadence; weights here are the snapshot taken on 2026-05-01 after the ARDX position was opened. Useful as a reference for what a top-end LLM picks when given a real book and a wide universe.
claude-experiment-2026-05-01 →10 Multibaggers
10Cross-thematic high-conviction list - companies the user expects to multibag over the next 5 years.
user-2026-04-25 →Top performers - 2026 YTD
18The 15 biggest YTD gainers across the AI-buildout universe as of 2026-05-02. Heavy concentration in optical transceivers (AAOI, LITE, VIAV), compound semis (AXTI, NVTS), memory (SNDK, WDC, MU), semi test (AEHR), and datacenter power (BE, VRT) - the picks-and-shovels of the capacity bottleneck.
user-X-2026-05-02 →White House Basket
13Trump-policy-aligned conviction picks - companies positioned to benefit from government ownership stakes, revenue-sharing arrangements, Golden Dome defense, and other policy-favored themes.
user-2026-04-25-whitehouse →Tema Space ETF
7Holdings of the new Tema Space ETF (US-listed names only). Excludes SpaceX (private), OHB (Frankfurt-listed), FPLSF (likely OTC EU).
user-2026-04-25-tema →Photonics & Power Watch
11User-supplied 2026-04-25 follow-up - display/RF/SiC semis + power + defense + photonics adjacencies. Theme/category to be refined per user input.
user-2026-04-25-followup →AI Infrastructure Stack
48The full-stack AI buildout mapped as 6 layers - silicon → systems → memory → optics → cloud → power. Bottleneck rank annotated where applicable: Memory is the #1 constraint today (HBM sold out through 2026), Networking/Optics is #2 (bandwidth demand exploding with inference), Power/Grid is #3 (multi-year structural). Capital rotates layer-by-layer as each bottleneck binds.
BD-investing-infographic-2026-05-02 →Korea - KOSPI Conviction Book
12KOSPI exposure for US-based investors. Most names accessible via OTC ADRs; KRX-direct names (.KS suffix) need IBKR or a similar broker with Korea cash-equity access. Korea Discount is structurally narrowing - Value-Up Index +130% since Sep-2024, KOSPI +75% YoY, Macquarie projects +48% earnings growth for 2026, bank payout ratios mandated 36% → 50%+ by year-end. Holdco names (HYMTF, SSGQF, 402340.KS) trade at 40-50%+ NAV discounts - the "bargain bin" the user flagged. Memory leg overlaps with the AI memory bubble.
own-research-2026-05-02 →Popular Stocks by PEG · 2026-05-03
21PEG-ratio snapshot of 21 popular AI / mega-cap names, ranked high → low. PEG > 2 is the editorial "danger zone" (rich vs. expected growth); PEG < 1 flags potentially mispriced growth. Notable: NVDA, AMD, AVGO, MU all sit at PEG < 1 despite being the most-watched names in the AI buildout - growth still outpaces the multiple. PEG moves daily; this is a one-day snapshot, not a live tracker.
tweet-stocksavvyshay-2026-05-03 →Photonics Stack - 8-layer breakdown
27The entire photonics value chain mapped end-to-end, from MOCVD reactors to AI-cluster optical switches. Front-end fabrication (layers 1-4) covers equipment, photonic ICs, discrete components, and substrates. Back-end fabrication (layers 5-8) covers transceivers, packaging, test, and systems. Each layer flags one "top pick" (★) per The Analyst's framework. Companion to the $LYTE ETF coverage - same universe, different lens: the ETF wraps the thesis, this watchlist breaks it down by capability layer.
x-the-analyst-2026-05-21 →Below SPX Forward PE · 2026-05-03
1010 popular AI / mega-cap names trading below the S&P 500's 2026 forward earnings multiple (~22-23x). Ranked cheapest first: MU at 6x, SNDK at 8x, then ADBE, TTD, PATH, CRM, QCOM, META, OKTA, NOW. Convergent with prior screens - MU and SNDK keep showing up across YTD performers, the DRAM ETF, and the PEG snapshot. Multiples move daily; this is a one-day snapshot, not a live tracker.
tweet-stocksavvyshay-2026-05-03 →Global Space Industry Enablers 2026
3939 publicly-traded space enablers across 4 layers - Orbital Launch, Manufacturing & Supply, Satellite Operators, Space Infrastructure. Editorial thesis: 2026 is the "summer of space" with SpaceX IPO as forcing function (~92% implied prob, rumored $2T valuation), Golden Dome missile-defense buildout, and rising launch + satellite + defense demand. SpaceX itself is private and excluded; ULA exposure is via its parents BA and LMT (placed in M&S). Heavy in defense primes (RTX, LMT, NOC, BA, LHX, GE, HON) and pure-play sat ops (RKLB, ASTS, PL, IRDM, BKSY).
tweet-stocksavvyshay-2026-05-02 →The Leading Stocks · 2026-05-03
5049 momentum-ranked stocks across three editorial tiers - Market Leaders (go-to names), Next-Gen Leaders (young high-growth), and Speculative Leaders (story stocks with momentum). Sourced from fullstackinvestor.co's leaderboard, snapshot taken 2026-05-03. YTD performance ranges from +47% (Aeluma) to +458% (AXT). Heavy Memory + Power + Optical/Photonics representation in the top tier - convergent with our DRAM bubble + Datacenter Power theme.
fullstackinvestor.co via tweet @Speculator_io 2026-05-03 →Semiconductors by Forward PE · 2026-05-03
2830 semiconductor stocks with > $50B market cap ranked cheapest first on next-fiscal-year forward P/E. Memory + Asian names dominate the cheap end (SK Hynix 4.3x, Samsung 5.1x, MU 5.4x - all PEG <0.3); Arm sits at the top at 98.5x / PEG 4.67. NVDA, AVGO, AMD all sit at PEG <0.5 - convergent with the 038 PEG snapshot. Includes 9 foreign tickers (OTC ADRs + 2 China-domestic) so PEG and growth comparison spans the full global semi universe; foreign tickers do not get auto-populated earnings dates. PEG = fwd P/E ÷ next-year EPS growth; N.M. when growth is flat/negative.
tweet-intheassembly-2026-05-03 →Top 5 for the Next Decade · 2026-05-03
5Five-stock conviction list framed as long-duration buys riding the AI revolution - semiconductors (NVDA AI GPUs, AVGO custom chips, TSM foundry), cloud AI (MSFT Azure), and next-gen healthcare (LLY GLP-1). Editorial framing from the source; not financial advice.
tweet @FIREDUpWealth 2026-05-03 →Semis 1-Month Performance · 2026-05-02
1818 semiconductor names ranked by 1-month return as of 2026-05-02. Editorial signal: a sector beta catch-up month - laggards led (INTC +107%, CRDO +92%, ALAB +91%, AMD +72%) while YTD winners cooled (NVDA last at +13%). Memory mid-pack (MU +47%) despite cheapest on PEG. Design tools rallied (SNPS +23%, CDNS +22%, ARM +36%). 1-month windows roll daily; the date is in the slug.
tweet-jonerlichman-2026-05-02 →Roundhill ETFs by Sector
12Roundhill's full ETF lineup grouped by sector: single-ticker baskets spanning memory, AI, big tech, robotics, gaming, luxury, and factor strategies. Click any ticker for the live ETF page.
roundhill-lineup-2026-06-05 →Apple iPhone 15 Chip Suppliers
11The 11 publicly traded chip suppliers inside an iPhone 15 Pro, mapped to the three boards they sit on (Logic / Memory / Radio Frequency). Sourced from Quartr's teardown infographic of the device. Apple-revenue concentration matters here: CRUS is ~80% Apple-dependent, SWKS ~55%, QRVO ~30%, while diversified names like QCOM/AVGO/TXN have Apple as one of many customers. Useful for read-throughs from iPhone unit-volume data into single-name supplier earnings.
tweet-investmentbook1-2026-05-03 →Trump-Praised Stocks
9Companies Donald Trump has personally praised or championed on the public record - investment-commitment shout-outs, White House events, named CEO endorsements. Rhetorical-signal basket, not a 13F.
editorial →Jensen-Praised Stocks
15Companies NVIDIA CEO Jensen Huang has publicly praised or named as flagship partners - GTC keynote shout-outs, earnings-call name-drops, joint AI-factory announcements. The "Jensen on stage with them" book.
editorial →Robotics Supply Chain (Rand Group)
50Public-equity map of the humanoid + industrial robotics stack. Two layers - Brain (compute/software/semis) and Body (actuators/sensors/connectors/automation) - sourced from @randgroup. 50 picks across 13 categories. Underlying thesis: $725B AI capex in 2026, Tesla Optimus mass-production ramp, Hyundai humanoids already in service.
@randgroup tweet 2026-05-12 →AI Drug Discovery
4Pure-play AI-driven drug-discovery platforms - generative biology, computational chemistry, antibody design, and protein-structure prediction applied to therapeutic pipelines. Companies where AI is the differentiator, not a buzzword bolted onto a traditional biotech. Seed members are 2026's 4 cleanest public listings on this thesis; the basket will grow as new IPOs land and Insitro-class private names go public.
editorial 2026-05-18 →“Never” is a discipline, not a dogma.
There are real reasons to sell — so we always name them first. Own great businesses, write down the few conditions that would break the thesis, and ignore everything else. That's the whole method. Nothing here is investment advice; it's research meant to make you a calmer owner.
A companion to QuantAbundancia — where the same names get traded.